Skip to main content
Log in

Canadian patients with Parkinson's disease (PD) have received good news regarding levodopa/carbidopa/entacapone

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Novartis Pharmaceuticals Canada Inc.Canadian Parkinson's disease patients one step closer to having access to modern treatment. Media Release: 22 Oct 2008. Available from: URL: http://www.novartis.ca

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Canadian patients with Parkinson's disease (PD) have received good news regarding levodopa/carbidopa/entacapone. Pharmacoecon. Outcomes News 565, 11 (2008). https://doi.org/10.2165/00151234-200805650-00030

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805650-00030

Keywords

Navigation